“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did not meet its ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

New Delhi: Stem cell therapies are a safe and effective way of treating Parkinson's disease, according to results of two ...

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández University of Elche (UMH, Spain) has developed a new method to deliver cell ...

As we age, blood stem cells, the essential source of new blood cells in the body, can accumulate genetic mutations.

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

An independent Data Safety Monitoring Board (DSMB) has recommended the continuation of BioCardia's Phase I/II CardiALLO-HF ...

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of ...

The trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.